Cargando…
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop
This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken in the midst of the pandemic. It reviews the early efforts of international and national insti...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841214/ https://www.ncbi.nlm.nih.gov/pubmed/35210119 http://dx.doi.org/10.1016/j.vaccine.2022.02.004 |
_version_ | 1784650788403937280 |
---|---|
author | Williams, Eloise Craig, Kathrine Chiu, Christopher Davies, Hugh Ellis, Stephanie Emerson, Claudia Jamrozik, Euzebiusz Jefford, Monica Kang, Gagandeep Kapulu, Melissa Kolstoe, Simon E. Littler, Katherine Lockett, Anthony Elena Rey Messer, Janet McShane, Helen Saenz, Carla Selgelid, Michael J. Shah, Seema Smith, Peter G. Yamazaki, Naho |
author_facet | Williams, Eloise Craig, Kathrine Chiu, Christopher Davies, Hugh Ellis, Stephanie Emerson, Claudia Jamrozik, Euzebiusz Jefford, Monica Kang, Gagandeep Kapulu, Melissa Kolstoe, Simon E. Littler, Katherine Lockett, Anthony Elena Rey Messer, Janet McShane, Helen Saenz, Carla Selgelid, Michael J. Shah, Seema Smith, Peter G. Yamazaki, Naho |
author_sort | Williams, Eloise |
collection | PubMed |
description | This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken in the midst of the pandemic. It reviews the early efforts of international and national institutions to define the ethical standards required for COVID-19 human challenge studies and create the frameworks to ensure rigorous and timely review of these studies. This report evaluates the utility of the WHO’s international guidance document Key criteria for the ethical acceptability of COVID-19 human challenge studies (WHO Key Criteria) as a practical resource for the ethics review of COVID-19 human challenge studies. It also assesses the UK HRA’s approach to these complex ethics reviews, including the formation of a Specialist Ad-Hoc Research Ethics Committee (REC) for COVID-19 Human Challenge Studies to review all current and future COVID-19 human challenge studies. In addition, the report outlines the reflections of REC members and researchers regarding the ethics review process of the first COVID-19 human challenge studies. Finally, it considers the potential ongoing scientific justification for COVID-19 human challenge studies, particularly in relation to next-generation vaccines and optimisation of vaccination schedules. Overall, there was broad agreement that the WHO Key Criteria represented an international consensus document that played a powerful role in setting norms and delineating the necessary conditions for the ethical acceptability of COVID-19 human challenge studies. Workshop members suggested that the WHO Key Criteria could be practically implemented to support researchers and ethics reviewers, including in the training of ethics committee members. In future, a wider audience may be engaged by the original document and potential additional materials, informed by the experiences of those involved in the first COVID-19 human challenge studies outlined in this document. |
format | Online Article Text |
id | pubmed-8841214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88412142022-02-14 Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop Williams, Eloise Craig, Kathrine Chiu, Christopher Davies, Hugh Ellis, Stephanie Emerson, Claudia Jamrozik, Euzebiusz Jefford, Monica Kang, Gagandeep Kapulu, Melissa Kolstoe, Simon E. Littler, Katherine Lockett, Anthony Elena Rey Messer, Janet McShane, Helen Saenz, Carla Selgelid, Michael J. Shah, Seema Smith, Peter G. Yamazaki, Naho Vaccine Conference Report This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken in the midst of the pandemic. It reviews the early efforts of international and national institutions to define the ethical standards required for COVID-19 human challenge studies and create the frameworks to ensure rigorous and timely review of these studies. This report evaluates the utility of the WHO’s international guidance document Key criteria for the ethical acceptability of COVID-19 human challenge studies (WHO Key Criteria) as a practical resource for the ethics review of COVID-19 human challenge studies. It also assesses the UK HRA’s approach to these complex ethics reviews, including the formation of a Specialist Ad-Hoc Research Ethics Committee (REC) for COVID-19 Human Challenge Studies to review all current and future COVID-19 human challenge studies. In addition, the report outlines the reflections of REC members and researchers regarding the ethics review process of the first COVID-19 human challenge studies. Finally, it considers the potential ongoing scientific justification for COVID-19 human challenge studies, particularly in relation to next-generation vaccines and optimisation of vaccination schedules. Overall, there was broad agreement that the WHO Key Criteria represented an international consensus document that played a powerful role in setting norms and delineating the necessary conditions for the ethical acceptability of COVID-19 human challenge studies. Workshop members suggested that the WHO Key Criteria could be practically implemented to support researchers and ethics reviewers, including in the training of ethics committee members. In future, a wider audience may be engaged by the original document and potential additional materials, informed by the experiences of those involved in the first COVID-19 human challenge studies outlined in this document. Elsevier Science 2022-06-09 2022-02-14 /pmc/articles/PMC8841214/ /pubmed/35210119 http://dx.doi.org/10.1016/j.vaccine.2022.02.004 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Conference Report Williams, Eloise Craig, Kathrine Chiu, Christopher Davies, Hugh Ellis, Stephanie Emerson, Claudia Jamrozik, Euzebiusz Jefford, Monica Kang, Gagandeep Kapulu, Melissa Kolstoe, Simon E. Littler, Katherine Lockett, Anthony Elena Rey Messer, Janet McShane, Helen Saenz, Carla Selgelid, Michael J. Shah, Seema Smith, Peter G. Yamazaki, Naho Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop |
title | Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop |
title_full | Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop |
title_fullStr | Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop |
title_full_unstemmed | Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop |
title_short | Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop |
title_sort | ethics review of covid-19 human challenge studies: a joint hra/who workshop |
topic | Conference Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841214/ https://www.ncbi.nlm.nih.gov/pubmed/35210119 http://dx.doi.org/10.1016/j.vaccine.2022.02.004 |
work_keys_str_mv | AT williamseloise ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT craigkathrine ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT chiuchristopher ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT davieshugh ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT ellisstephanie ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT emersonclaudia ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT jamrozikeuzebiusz ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT jeffordmonica ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT kanggagandeep ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT kapulumelissa ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT kolstoesimone ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT littlerkatherine ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT lockettanthony ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT elenarey ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT messerjanet ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT mcshanehelen ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT saenzcarla ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT selgelidmichaelj ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT shahseema ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT smithpeterg ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop AT yamazakinaho ethicsreviewofcovid19humanchallengestudiesajointhrawhoworkshop |